HK1107354A1 - INDUSTRIAL PROCESS FOR THE PREPARATION OF 17-HYDROXY-6ß,7ß;15ß,16ß- BISMETHYLENE-3-OXO-17a-PREGN-4-ENE-21-CARBOXYLIC ACID GAMMA LACTONE AND KEY INTERMEDIATES FOR THIS PROCESS - Google Patents

INDUSTRIAL PROCESS FOR THE PREPARATION OF 17-HYDROXY-6ß,7ß;15ß,16ß- BISMETHYLENE-3-OXO-17a-PREGN-4-ENE-21-CARBOXYLIC ACID GAMMA LACTONE AND KEY INTERMEDIATES FOR THIS PROCESS

Info

Publication number
HK1107354A1
HK1107354A1 HK08101261.2A HK08101261A HK1107354A1 HK 1107354 A1 HK1107354 A1 HK 1107354A1 HK 08101261 A HK08101261 A HK 08101261A HK 1107354 A1 HK1107354 A1 HK 1107354A1
Authority
HK
Hong Kong
Prior art keywords
bismethylene
pregn
ene
oxo
hydroxy
Prior art date
Application number
HK08101261.2A
Other languages
English (en)
Inventor
Bela Soeroes
Judit Horvath
Gyoergy Galik
Jozsef Bodi
Zoltan Tuba
Sandor Maho
Gabor Balogh
Antal Aranyi
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of HK1107354A1 publication Critical patent/HK1107354A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Lubricants (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Pyrane Compounds (AREA)
HK08101261.2A 2004-11-30 2008-02-01 INDUSTRIAL PROCESS FOR THE PREPARATION OF 17-HYDROXY-6ß,7ß;15ß,16ß- BISMETHYLENE-3-OXO-17a-PREGN-4-ENE-21-CARBOXYLIC ACID GAMMA LACTONE AND KEY INTERMEDIATES FOR THIS PROCESS HK1107354A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0402465A HUP0402465A2 (en) 2004-11-30 2004-11-30 Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main intermediates of the process
PCT/HU2005/000110 WO2006059167A1 (en) 2004-11-30 2005-10-11 INDUSTRIAL PROCESS FOR THE PREPARATION OF 17-HYDROXY-6β,7β;15β,16β-BISMETHYLENE-3-OXO-17α-PREGN-4-ENE-21-CARBOXYLIC ACID Ϝ-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS

Publications (1)

Publication Number Publication Date
HK1107354A1 true HK1107354A1 (en) 2008-04-03

Family

ID=89985651

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08101261.2A HK1107354A1 (en) 2004-11-30 2008-02-01 INDUSTRIAL PROCESS FOR THE PREPARATION OF 17-HYDROXY-6ß,7ß;15ß,16ß- BISMETHYLENE-3-OXO-17a-PREGN-4-ENE-21-CARBOXYLIC ACID GAMMA LACTONE AND KEY INTERMEDIATES FOR THIS PROCESS

Country Status (17)

Country Link
US (1) US8309712B2 (xx)
EP (1) EP1817326B1 (xx)
JP (1) JP4971179B2 (xx)
CN (1) CN101061133B (xx)
AT (1) ATE468349T1 (xx)
AU (1) AU2005311059B2 (xx)
CA (1) CA2585802C (xx)
CY (1) CY1110098T1 (xx)
DE (1) DE602005021395D1 (xx)
DK (1) DK1817326T3 (xx)
ES (1) ES2345560T3 (xx)
HK (1) HK1107354A1 (xx)
HU (1) HUP0402465A2 (xx)
PL (1) PL1817326T3 (xx)
PT (1) PT1817326E (xx)
SI (1) SI1817326T1 (xx)
WO (1) WO2006059167A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042338A1 (it) * 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
ES2355586T3 (es) 2007-07-26 2011-03-29 Newchem S.P.A. Procedimiento de preparación de drospirenona.
WO2009111574A2 (en) * 2008-03-05 2009-09-11 Evestra, Inc. BISMETHYLENE-17α CARBOLACTONES AND RELATED USES
WO2010068500A2 (en) * 2008-11-25 2010-06-17 Evestra, Inc. PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES
US8334375B2 (en) * 2009-04-10 2012-12-18 Evestra, Inc. Methods for the preparation of drospirenone
DE102009038972A1 (de) * 2009-08-23 2011-06-30 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG, 14167 Verfahren zur Herstellung von Drospirenon aus 6,7,15,16-Dimethylenandrost-4-en-3,17-dion
DE102009031907B4 (de) * 2009-07-01 2017-02-09 Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg Verfahren zur Herstellung von Drospirenon aus Androstendion
DE102009031908B4 (de) * 2009-07-01 2017-02-09 Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg Verfahren zur Herstellung von Drospirenon aus 15-Hydroxyandrostendion
DE102009031909B4 (de) * 2009-07-01 2017-02-09 Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg Verfahren zur Herstellung von Drospirenon aus Prasteron
CN109232700B (zh) * 2018-09-17 2020-06-26 宁波三生生物科技有限公司 一种烯丙孕素的高效合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH540896A (de) 1966-04-02 1973-10-15 Schering Ag Verfahren zur Herstellung von 15,16B-Methylensteroiden
CH510002A (de) 1968-04-22 1971-07-15 Hoffmann La Roche Verfahren zur Herstellung neuer Pregnene
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2746298A1 (de) * 1977-10-13 1979-04-19 Schering Ag 4-androsten-3,17-dion-derivate, ihre herstellung und verwendung
DE3042136A1 (de) 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
DE3265852D1 (en) 1981-09-21 1985-10-03 Schering Ag 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens

Also Published As

Publication number Publication date
SI1817326T1 (sl) 2010-08-31
PL1817326T3 (pl) 2010-10-29
CA2585802A1 (en) 2006-06-08
ATE468349T1 (de) 2010-06-15
DE602005021395D1 (de) 2010-07-01
US20080200668A1 (en) 2008-08-21
JP4971179B2 (ja) 2012-07-11
JP2008521875A (ja) 2008-06-26
CN101061133B (zh) 2011-01-26
HUP0402465A2 (en) 2006-07-28
DK1817326T3 (da) 2010-08-30
EP1817326B1 (en) 2010-05-19
PT1817326E (pt) 2010-06-25
CY1110098T1 (el) 2015-01-14
AU2005311059A1 (en) 2006-06-08
US8309712B2 (en) 2012-11-13
CN101061133A (zh) 2007-10-24
EP1817326A1 (en) 2007-08-15
AU2005311059B2 (en) 2011-01-06
WO2006059167A1 (en) 2006-06-08
HU0402465D0 (en) 2005-01-28
CA2585802C (en) 2009-09-08
ES2345560T3 (es) 2010-09-27

Similar Documents

Publication Publication Date Title
HK1107354A1 (en) INDUSTRIAL PROCESS FOR THE PREPARATION OF 17-HYDROXY-6ß,7ß;15ß,16ß- BISMETHYLENE-3-OXO-17a-PREGN-4-ENE-21-CARBOXYLIC ACID GAMMA LACTONE AND KEY INTERMEDIATES FOR THIS PROCESS
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
DE502006006854D1 (de) Substituierte benzo (d) isoaxol-3-yl-amin-verbindungen als analgetika
TW200614996A (en) Antiviral compounds
UA91688C2 (xx) Антивірусні сполуки$антивирусные соединения
TNSN07196A1 (en) Potentiators of glutamate receptors
MX339476B (es) Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso.
TW200738742A (en) Antiviral compounds
MY136668A (en) Acetone solvate of dimethoxydocetaxel and its process of preparation
TW200640912A (en) Novel processes for the preparation of a 2H-chromene
PL1668001T3 (pl) Podstawione heteroarylobenzofuranowe kwasy
MX2007010143A (es) Formas cristalinas de intermedio de linezolid.
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
EP1825856A4 (en) ORAL COMPOSITION CONTAINING DIFRUCTOSE ANHYDRIDE
GB0327323D0 (en) Novel pharmaceuticals
TW200510323A (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
PT1893597E (pt) Potenciadores do receptor ampa
TW200728267A (en) Processes and intermediates for the preparation of prostaglandins
TW200613271A (en) Crystalline forms of 1,24(s)-dihydroxy vitamin d2
IL178228A (en) Process for the semisynthesis of deserpidine
WO2010131118A3 (en) Polymorphs of etravirine and processes for preparation thereof
UA92464C2 (xx) Противірусні сполуки[противовирусные соединения
TW200700389A (en) 5h-benzocycloheptene derivatives, process for their production and their use as anti-inflammatory agents